Clover Biopharmaceuticals
Cecilia Wang serves as the Senior Manager of Business Development & Strategy at Clover Biopharmaceuticals since August 2022, following a consultancy role at the Bill & Melinda Gates Foundation in early 2022. Previously, Wang held positions including Corporate Strategy Intern at Clover Biopharmaceuticals, Associate Consultant Intern at Mastercard, Data Analytics Intern at the National Institutes of Health, and Business Analyst Intern at Bo Le Associates. Academic achievements include dual Master's degrees in Global Affairs from Schwarzman Scholars and Tsinghua University, and dual Bachelor's degrees in Economics and Computational Biology from The Wharton School and the University of Pennsylvania, respectively. Experience in market research, data analytics, and strategic consulting underscores Wang's dedication to healthcare and technology industries.
This person is not in any offices
Clover Biopharmaceuticals
2 followers
Clover Biopharmaceuticals is a global, clinical-stage, research-based biotechnology company focused on discovering, developing and commercializing transformative biologic therapies, with a focus on oncology and autoimmune diseases.